As of 2025-09-17, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (157.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.95 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -1862.2%.
The range of the Relative Valuation is (153.68) - (161.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 13.5x | 13.1x |
| Forward P/E multiples | 12.7x - 13.4x | 13.0x |
| Fair Price | (153.68) - (161.40) | (157.72) |
| Upside | -1817.0% - -1903.3% | -1862.2% |
| Date | P/E |
| 2025-09-08 | -0.92 |
| 2025-09-05 | -0.94 |
| 2025-09-04 | -0.89 |
| 2025-09-03 | -0.90 |
| 2025-09-02 | -0.88 |
| 2025-08-29 | -0.87 |
| 2025-08-28 | -0.92 |
| 2025-08-27 | -0.94 |
| 2025-08-26 | -0.91 |
| 2025-08-25 | -0.85 |
| 2025-08-22 | -0.85 |
| 2025-08-21 | -0.82 |
| 2025-08-20 | -0.73 |
| 2025-08-19 | -0.73 |
| 2025-08-18 | -0.73 |
| 2025-08-15 | -0.64 |
| 2025-08-14 | -0.63 |
| 2025-08-13 | -0.63 |
| 2025-08-12 | -0.62 |
| 2025-08-11 | -0.63 |
| 2025-08-08 | -0.64 |
| 2025-08-07 | -0.67 |
| 2025-08-06 | -0.67 |
| 2025-08-05 | -0.66 |
| 2025-08-04 | -0.66 |
| 2025-08-01 | -0.62 |
| 2025-07-31 | -0.60 |
| 2025-07-30 | -0.66 |
| 2025-07-29 | -0.67 |
| 2025-07-28 | -0.73 |
| 2025-07-25 | -0.76 |
| 2025-07-24 | -0.74 |
| 2025-07-23 | -0.77 |
| 2025-07-22 | -0.76 |
| 2025-07-21 | -0.72 |
| 2025-07-18 | -0.76 |
| 2025-07-17 | -0.75 |
| 2025-07-16 | -0.72 |
| 2025-07-15 | -0.70 |
| 2025-07-14 | -0.72 |
| 2025-07-11 | -0.69 |
| 2025-07-10 | -0.73 |
| 2025-07-09 | -0.72 |
| 2025-07-08 | -0.68 |
| 2025-07-07 | -0.62 |
| 2025-07-03 | -0.65 |
| 2025-07-02 | -0.61 |
| 2025-07-01 | -0.61 |
| 2025-06-30 | -0.60 |
| 2025-06-27 | -0.60 |